Modelling onchocerciasis-associated epilepsy and the impact of ivermectin treatment on its prevalence and incidence.

Stapley JN, Hamley JID, Walker M, Dixon MA, Colebunders R, Basáñez MG

Open source

DOI
10.1038/s41467-024-50582-9
Published
2024 Jul 25
Container
Nature communications
Publisher
Not recorded
Open access
yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1038/s41467-024-50582-9,
  title = {Modelling onchocerciasis-associated epilepsy and the impact of ivermectin treatment on its prevalence and incidence.},
  author = {Stapley JN and Hamley JID and Walker M and Dixon MA and Colebunders R and Basáñez MG},
  year = {2024},
  journal = {Nature communications},
  doi = {10.1038/s41467-024-50582-9},
  url = {https://doi.org/10.1038/s41467-024-50582-9}
}

RIS

TY  - JOUR
TI  - Modelling onchocerciasis-associated epilepsy and the impact of ivermectin treatment on its prevalence and incidence.
AU  - Stapley JN
AU  - Hamley JID
AU  - Walker M
AU  - Dixon MA
AU  - Colebunders R
AU  - Basáñez MG
PY  - 2024
JO  - Nature communications
DO  - 10.1038/s41467-024-50582-9
UR  - https://doi.org/10.1038/s41467-024-50582-9
ER  - 

APA

JN, S., JID, H., M, W., MA, D., R, C., & MG, B. (2024). Modelling onchocerciasis-associated epilepsy and the impact of ivermectin treatment on its prevalence and incidence.. Nature communications. https://doi.org/10.1038/s41467-024-50582-9

Source records